Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction

被引:19
|
作者
Fassett, John [1 ]
Xu, Xin [4 ]
Kwak, Dongmin [2 ,3 ]
Zhu, Guangshuo [5 ]
Fassett, Erin K. [1 ]
Zhang, Ping [2 ,3 ]
Wang, Huan [2 ,3 ]
Mayer, Bernd [1 ]
Bache, Robert J. [1 ]
Chen, Yingjie [1 ]
机构
[1] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, Humboldtstr 46, A-8010 Graz, Austria
[2] Univ Minnesota, Cardiovasc Div, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA
[4] Shanghai Univ Sport, Dept Exercise Rehabil, Shanghai 200438, Peoples R China
[5] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
关键词
Adenosine; Adenosine kinase; Microtubules; Detyrosinated tubulin; Cardiac hypertrophy; CONTRACTILE DYSFUNCTION; CARDIAC-HYPERTROPHY; CYTOSKELETAL ROLE; HEART; INHIBITION; TUBULIN; TRAFFICKING;
D O I
10.1016/j.yjmcc.2019.03.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adenosine exerts numerous protective actions in the heart, including attenuation of cardiac hypertrophy. Adenosine kinase (ADK) converts adenosine to adenosine monophosphate (AMP) and is the major route of myocardial adenosine metabolism, however, the impact of ADK activity on cardiac structure and function is unknown. To examine the role of ADK in cardiac homeostasis and adaptation to stress, conditional cardiomyocyte specific ADK knockout mice (cADK(-/-)) were produced using the MerCreMer-lox-P system. Within 4 weeks of ADK disruption, cADK(-/-) mice developed spontaneous hypertrophy and increased beta-Myosin Heavy Chain expression without observable LV dysfunction. In response to 6 weeks moderate left ventricular pressure overload (transverse aortic constriction;TAC), wild type mice (WT) exhibited similar to 60% increase in ventricular ADK expression and developed LV hypertrophy with preserved LV function. In contrast, cADK(-/-) mice exhibited significantly greater LV hypertrophy and cardiac stress marker expression (atrial natrurietic peptide and beta-Myosin Heavy Chain), LV dilation, reduced LV ejection fraction and increased pulmonary congestion. ADK disruption did not decrease protein methylation, inhibit AMPK, or worsen fibrosis, but was associated with persistently elevated mTORC1 and p44/42 ERK MAP kinase signaling and a striking increase in microtubule (MT) stabilization/detyrosination. In neonatal cardiomyocytes exposed to hypertrophic stress, 2-chloroadenosine (CADO) or adenosine treatment suppressed MT detyrosination, which was reversed by ADK inhibition with iodotubercidin or ABT-702. Conversely, adenoviral over-expression of ADK augmented CADO destabilization of MTs and potentiated CADO attenuation of cardiomyocyte hypertrophy. Together, these findings indicate a novel adenosine receptor-independent role for ADK-mediated adenosine metabolism in cardiomyocyte microtubule dynamics and protection against maladaptive hypertrophy.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 50 条
  • [1] Cardiomyocyte-specific NOS3 overexpression protects against chronic pressure overload-induced LV hypertrophy and dysfunction.
    Janssens, SP
    Pokreisz, P
    Pellens, M
    Vermeersch, P
    Jans, P
    Gillijns, H
    Schoonjans, L
    Van de Werf, F
    Collen, D
    Bloch, K
    CIRCULATION, 2004, 110 (17) : 333 - 334
  • [2] Diacylglycerol kinase ζ attenuates pressure overload-induced cardiac hypertrophy
    Harada, Mutsuo
    Takeishi, Yasuchika
    Arimoto, Takanori
    Niizeki, Takeshi
    Kitahara, Tatsuro
    Goto, Kaoru
    Walsh, Richard A.
    Kubota, Isao
    CIRCULATION JOURNAL, 2007, 71 (02) : 276 - 282
  • [3] Shensongyangxin protects against pressure overload-induced cardiac hypertrophy
    Shen, Di-Fei
    Wu, Qing-Qing
    Ni, Jian
    Deng, Wei
    Wei, Cong
    Jia, Zhen-Hua
    Zhou, Heng
    Zhou, Meng-Qiao
    Bian, Zhou-Yan
    Tang, Qi-Zhu
    MOLECULAR MEDICINE REPORTS, 2016, 13 (01) : 980 - 988
  • [4] Cardiomyocyte number increases in pressure overload-induced hypertrophy
    Wilson, Rachel M.
    Chen, Xiongwen
    Kubo, Hajime
    Berretta, Remus M.
    Bearzi, Claudia
    Tillmanns, Jochen
    Leri, Annarosa
    Kajstura, Jan
    Anversa, Piero
    Houser, Steven R.
    CIRCULATION, 2006, 114 (18) : 305 - 305
  • [5] Hawthorn alters remodeling and ameliorates LV dysfunction in pressure overload-induced cardiac hypertrophy
    Hwang, Hyun Seok
    Ghannam, Michael M. J.
    Boluyt, Marvin O.
    Converso, Kimber
    Russell, Mark W.
    Bleske, Barry E.
    FASEB JOURNAL, 2007, 21 (06): : A1260 - A1260
  • [6] Stachydrine Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Suppressing Autophagy
    Cao, Tong-Tong
    Chen, Hui-Hua
    Dong, Zhiwei
    Xu, Yan-Wu
    Zhao, Pei
    Guo, Wei
    Wei, Hong-Chang
    Zhang, Chen
    Lu, Rong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (01) : 103 - 114
  • [7] Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy
    Yang, Liu
    Wu, Qing-Qing
    Liu, Yuan
    Hu, Zhe-Fu
    Bian, Zhou-Yan
    Tang, Qi-Zhu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 14345 - 14354
  • [8] Puerarin attenuates pressure overload-induced cardiac hypertrophy
    Yuan, Yuan
    Zong, Jing
    Zhou, Heng
    Bian, Zhou-Yan
    Deng, Wei
    Dai, Jia
    Gan, Hua-Wen
    Yang, Zheng
    Li, Hongliang
    Tang, Qi-Zhu
    JOURNAL OF CARDIOLOGY, 2014, 63 (1-2) : 73 - 81
  • [9] Evodiamine attenuates pressure overload-induced cardiac hypertrophy
    Li, Fangfang
    Yuan, Yuan
    Zhang, Ning
    Wu, Qingqing
    Li, Jin
    Zhou, Mengqiao
    Yang, Zheng
    Tang, Qizhu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (07): : 10202 - 10213
  • [10] Maslinic acid protects against pressure overload-induced cardiac hypertrophy in mice
    Liu, Yan-Ling
    Kong, Chun-Yan
    Song, Peng
    Zhou, Heng
    Zhao, Xing-Sheng
    Tang, Qi-Zhu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2018, 138 (02) : 116 - 122